Low-Density Lipoprotein Apheresis in Patients with Acute Kidney Injury Due to Minimal Change Disease Requiring Acute Renal Replacement Therapy

Low-density lipoprotein apheresis (LDL-A) has been developed as a therapy for familial hypercholesterolemia, but LDL-A has also been used as a general treatment for drug-resistant nephrotic syndrome (NS) due to focal segmental glomerulosclerosis (FSGS). The patients with NS due to minimal change dis...

Descripción completa

Detalles Bibliográficos
Autores principales: Terada, Kohsuke, Mugishima, Koji, Kawasaki, Sayuri, Itagaki, Fumiaki, Yamada, Takehisa, Sakai, Yukinao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Case Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7308121/
https://www.ncbi.nlm.nih.gov/pubmed/32606890
http://dx.doi.org/10.2147/IJNRD.S248610

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7308121/
https://www.ncbi.nlm.nih.gov/pubmed/32606890
http://dx.doi.org/10.2147/IJNRD.S248610

Ejemplares similares